We find that loss of SAGA complex KAT activity in MYCN-amplified neuroblastoma, through modulation of TADA2B, leads to a rapid and global loss of acetylation on H3K9, including in the promoters of actively transcribed genes. The gene discussed is MYCN; the disease is neuroblastoma.